PATENT CLAIM ANALYSIS

Application Number: 15895783
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "285000"]

Abstract:
Disclosed is the synthesis procedure for benzazolo[3,2-a]quinolinium chloride salts and the inclusion of chloro-substituent, amino-substituent, and nitro-substituent resulting in several compounds. The compounds are further used as markers due to their fluorescent properties including in hypoxic environments. This disclosure further describes anti-cancer screening of two BQS, namely, 7-benzyl-3-aminobenzimidazo[3,2-a]quinolinium chloride (ABQ-48: NSC D-763307) and the corresponding 7-benzyl-3-nitrobenzimidazo[3,2-a]quinolinium chloride (NBQ 48: NSC D-763303).

Claim (Index 1):
UAMGA method of treating cancer cells selected from the group consisting of non-small cell lung cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, and breast cancer in a mammal comprising administering to said mammal, a therapeutically effective amount of a benzazolo[3,2-a]quinolinium chloride salt compound of formula wherein R 1  is selected from a group consisting of 3-NH 2  and 3-NO 2 .

Metadata:
- Claim Count in Document: 36.0
- Percentile: 88.0
- Lexical Diversity: 1.45763
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14857500', '13364123', '12416174', '13520619', '14634940']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7278834015293544
- 35 USC 102 Novelty (BERT): 0.6118359938187273
- Combined Prediction Score: 0.7162786607582916
- Mean Citation Score: 341.1033260000001
- Max Citation Score: 525.2719999999998
- Similarity Product: 503.168906439781

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test